Orchestra BioMed Holdings (OBIO) Inventory (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Inventory came in at $277000.0 in Q1 2026, up 105.19% year-on-year from $135000.0 in Q1 2025, and down 10.65% on a QoQ basis from $310000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Inventory (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Inventory data on file, last reported at $277000.0 in Q1 2026.
- On a quarterly basis, Inventory rose 105.19% year-over-year to $277000.0 in Q1 2026; TTM through Mar 2026 was $277000.0, a 105.19% increase from a year earlier, with the FY2025 full-year figure at $310000.0, up 79.19% from the prior year.
- Inventory for Q1 2026 stood at $277000.0, down from $310000.0 in the prior quarter.
- Over the last five years, Inventory for OBIO reached as high as $365000.0 in Q3 2025 and fell as low as $70000.0 in Q2 2024.
- Historically, Inventory has averaged $202357.1 across 5 years, with a median of $181500.0 in 2023.
- Across the five-year window, Inventory tumbled 60.67% in 2024 and surged 164.29% in 2025, its largest moves.
- Year by year, Inventory stood at $276000.0 in 2022, then plunged by 47.1% to $146000.0 in 2023, then climbed by 18.49% to $173000.0 in 2024, then surged by 79.19% to $310000.0 in 2025, then slipped by 10.65% to $277000.0 in 2026.
- Per Business Quant data, the three most recent Inventory figures were $277000.0 in Q1 2026, $310000.0 in Q4 2025, and $365000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | 277,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 277,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Mar 31, 2023 | 232,000.00 |
| Dec 31, 2022 | 276,000.00 |